Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

GC-MS Analysis and Antiviral Efficacy of Lactiplantibacillus plantarum Postbiotic Extracts Against Infectious Haematopoietic Necrosis Virus.

Created on 19 Jun 2026

Authors

Mohammad Tamrin Mohamad Lal, Gilbert Ringgit, Zy Chee Wong, Leong Seng Lim, Fui Fui Ching, Ilham Misbakudin Al Zamzami, Abdul Aziz Jaziri, Muhamad Afiq Aziz, Hiroaki Saito, Motohiko Sano

Published in

Journal of fish diseases. Pages e70222. Jun 19, 2026. Epub Jun 19, 2026.

Abstract

Infectious haematopoietic necrosis virus (IHNV) causes devastating economic losses in salmonid aquaculture and effective control measures are urgently needed. This study investigates the anti-IHNV potential of postbiotics derived from Lactiplantibacillus plantarum. The crude postbiotic extract (PBP20o) and a neutralized version (PBP20a) were evaluated for cytotoxicity and antiviral activity in epithelioma papulosum cyprini (EPC) cells. Both extracts exhibited a safe concentration threshold of 1.15 μgmL-1. Remarkably, treatment with PBP20o and PBP20a at this non-cytotoxic concentration reduced IHNV titers by 0.82 log₁₀TCID₅₀/ml (84.9%) and 0.46 log₁₀TCID₅₀/ml (65.3%), respectively. The enhanced efficacy of the acidic extract might suggest a dual mechanism involving direct acid-mediated viral inactivation combined with the action of pH-stable bioactive metabolites. GC-MS identified three potential antiviral compounds, including such as trans-cinnamic acid (RT = 33.688, A% = 0.39), pyrrolo[1,2-a]pyrazine-1,4-dione, hexahydro-3-(2-methylpropyl) (RT = 48.516, A% = 13.54) and hexadecanamide (RT = 56.226, A% = 3.11) from L. plantarum postbiotic. This study identifies L. plantarum postbiotics as a novel and promising source of antiviral compounds, offering a potential alternative strategy for mitigating IHNV outbreaks in aquaculture while ensuring biosafety for the target host and end consumers.

PMID:
42318631
Bibliographic data and abstract were imported from PubMed on 19 Jun 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 8
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement